🇺🇸 FDA
Pipeline program

GLPG3970 film-coated tablet

GLPG3970-CL-102

Phase 1 small_molecule terminated

Quick answer

GLPG3970 film-coated tablet for Systemic Lupus Erythematosus is a Phase 1 program (small_molecule) at Lakefront Biotherapeutics NV with 1 ClinicalTrials.gov record(s).

Program details

Company
Lakefront Biotherapeutics NV
Indication
Systemic Lupus Erythematosus
Phase
Phase 1
Modality
small_molecule
Status
terminated

Clinical trials